Cargando…
Fibroblast Growth Factor 21 Levels Exhibit the Association With Renal Outcomes in Subjects With Type 2 Diabetes Mellitus
BACKGROUND: Whether microalbuminuria predicts renal outcomes in patients with type 2 diabetes mellitus (T2DM) is argued. Fibroblast growth factor 21 (FGF-21) levels were elevated by the pathogenic process of diabetic kidney disease. The purpose of the study was to evaluate the associations of FGF-21...
Autores principales: | Chang, Li-Hsin, Chu, Chia-Huei, Huang, Chin-Chou, Lin, Liang-Yu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9069677/ https://www.ncbi.nlm.nih.gov/pubmed/35528011 http://dx.doi.org/10.3389/fendo.2022.846018 |
Ejemplares similares
-
Fibroblast Growth Factor 21-Null Mice Do Not Exhibit an Impaired Response to Fasting
por: Antonellis, Patrick Joseph, et al.
Publicado: (2016) -
Plasma Levels of Myonectin But Not Myostatin or Fibroblast-Derived Growth Factor 21 Are Associated with Insulin Resistance in Adult Humans without Diabetes Mellitus
por: Toloza, Freddy J. K., et al.
Publicado: (2018) -
Circulating Fibroblast Growth Factor 21 and Total Testosterone in Type 2 Diabetes Mellitus Men With Coronary Heart Disease
por: Mei, Yufeng, et al.
Publicado: (2022) -
Fibroblast Growth Factor 19 in Gestational Diabetes Mellitus and Fetal Growth
por: Yang, Meng-Nan, et al.
Publicado: (2022) -
Fibroblast growth factor 21 in metabolic syndrome
por: Yang, Ming, et al.
Publicado: (2023)